Triumvira Cleared to Begin Clinical Testing of TAC01-CD19 in B-cell Lymphomas
News
Triumvira Immunulogics is launching a Phase 1/2 clinical trial to test its T-cell therapy candidate, TAC01-CD19, in patients with B-cell lymphoma across the U.S. and Canada, the company announced. The ... Read more